Global Bicyclic Peptide Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Bicyclic Peptide Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
  • 1.3.2 Romidepsin
  • 1.3.3 Phalloidin
  • 1.3.4 Others
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Bicyclic Peptide Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
  • 1.4.2 Anti-Cancer
  • 1.4.3 Antibacterial
  • 1.4.4 Others
• 1.5 Global Bicyclic Peptide Drugs Market Size & Forecast
  • 1.5.1 Global Bicyclic Peptide Drugs Consumption Value (2019 & 2023 & 2030)
  • 1.5.2 Global Bicyclic Peptide Drugs Sales Quantity (2019-2030)
  • 1.5.3 Global Bicyclic Peptide Drugs Average Price (2019-2030)

2 Manufacturers Profiles

• 2.1 Bicycle Therapeutics
  • 2.1.1 Bicycle Therapeutics Details
  • 2.1.2 Bicycle Therapeutics Major Business
  • 2.1.3 Bicycle Therapeutics Bicyclic Peptide Drugs Product and Services
  • 2.1.4 Bicycle Therapeutics Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.1.5 Bicycle Therapeutics Recent Developments/Updates
• 2.2 Apellis Pharmaceuticals
  • 2.2.1 Apellis Pharmaceuticals Details
  • 2.2.2 Apellis Pharmaceuticals Major Business
  • 2.2.3 Apellis Pharmaceuticals Bicyclic Peptide Drugs Product and Services
  • 2.2.4 Apellis Pharmaceuticals Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.2.5 Apellis Pharmaceuticals Recent Developments/Updates
• 2.3 Merck
  • 2.3.1 Merck Details
  • 2.3.2 Merck Major Business
  • 2.3.3 Merck Bicyclic Peptide Drugs Product and Services
  • 2.3.4 Merck Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.3.5 Merck Recent Developments/Updates
• 2.4 Thermo Fisher
  • 2.4.1 Thermo Fisher Details
  • 2.4.2 Thermo Fisher Major Business
  • 2.4.3 Thermo Fisher Bicyclic Peptide Drugs Product and Services
  • 2.4.4 Thermo Fisher Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.4.5 Thermo Fisher Recent Developments/Updates
• 2.5 ApexBio Technology
  • 2.5.1 ApexBio Technology Details
  • 2.5.2 ApexBio Technology Major Business
  • 2.5.3 ApexBio Technology Bicyclic Peptide Drugs Product and Services
  • 2.5.4 ApexBio Technology Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.5.5 ApexBio Technology Recent Developments/Updates
• 2.6 BPS Bioscience
  • 2.6.1 BPS Bioscience Details
  • 2.6.2 BPS Bioscience Major Business
  • 2.6.3 BPS Bioscience Bicyclic Peptide Drugs Product and Services
  • 2.6.4 BPS Bioscience Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.6.5 BPS Bioscience Recent Developments/Updates
• 2.7 Selleck Chemicals
  • 2.7.1 Selleck Chemicals Details
  • 2.7.2 Selleck Chemicals Major Business
  • 2.7.3 Selleck Chemicals Bicyclic Peptide Drugs Product and Services
  • 2.7.4 Selleck Chemicals Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.7.5 Selleck Chemicals Recent Developments/Updates
• 2.8 AdooQ BioScience
  • 2.8.1 AdooQ BioScience Details
  • 2.8.2 AdooQ BioScience Major Business
  • 2.8.3 AdooQ BioScience Bicyclic Peptide Drugs Product and Services
  • 2.8.4 AdooQ BioScience Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.8.5 AdooQ BioScience Recent Developments/Updates
• 2.9 Cayman Chemical Company
  • 2.9.1 Cayman Chemical Company Details
  • 2.9.2 Cayman Chemical Company Major Business
  • 2.9.3 Cayman Chemical Company Bicyclic Peptide Drugs Product and Services
  • 2.9.4 Cayman Chemical Company Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.9.5 Cayman Chemical Company Recent Developments/Updates
• 2.10 Santa Cruz Biotechnology
  • 2.10.1 Santa Cruz Biotechnology Details
  • 2.10.2 Santa Cruz Biotechnology Major Business
  • 2.10.3 Santa Cruz Biotechnology Bicyclic Peptide Drugs Product and Services
  • 2.10.4 Santa Cruz Biotechnology Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.10.5 Santa Cruz Biotechnology Recent Developments/Updates
• 2.11 TargetMol Chemicals
  • 2.11.1 TargetMol Chemicals Details
  • 2.11.2 TargetMol Chemicals Major Business
  • 2.11.3 TargetMol Chemicals Bicyclic Peptide Drugs Product and Services
  • 2.11.4 TargetMol Chemicals Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.11.5 TargetMol Chemicals Recent Developments/Updates
• 2.12 Abcam
  • 2.12.1 Abcam Details
  • 2.12.2 Abcam Major Business
  • 2.12.3 Abcam Bicyclic Peptide Drugs Product and Services
  • 2.12.4 Abcam Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.12.5 Abcam Recent Developments/Updates
• 2.13 Biotium
  • 2.13.1 Biotium Details
  • 2.13.2 Biotium Major Business
  • 2.13.3 Biotium Bicyclic Peptide Drugs Product and Services
  • 2.13.4 Biotium Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.13.5 Biotium Recent Developments/Updates
• 2.14 Cayman Chemical
  • 2.14.1 Cayman Chemical Details
  • 2.14.2 Cayman Chemical Major Business
  • 2.14.3 Cayman Chemical Bicyclic Peptide Drugs Product and Services
  • 2.14.4 Cayman Chemical Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.14.5 Cayman Chemical Recent Developments/Updates
• 2.15 Apollo Scientific
  • 2.15.1 Apollo Scientific Details
  • 2.15.2 Apollo Scientific Major Business
  • 2.15.3 Apollo Scientific Bicyclic Peptide Drugs Product and Services
  • 2.15.4 Apollo Scientific Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.15.5 Apollo Scientific Recent Developments/Updates
• 2.16 Tocris Bioscience
  • 2.16.1 Tocris Bioscience Details
  • 2.16.2 Tocris Bioscience Major Business
  • 2.16.3 Tocris Bioscience Bicyclic Peptide Drugs Product and Services
  • 2.16.4 Tocris Bioscience Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.16.5 Tocris Bioscience Recent Developments/Updates
• 2.17 Ningbo Inno Pharmchem
  • 2.17.1 Ningbo Inno Pharmchem Details
  • 2.17.2 Ningbo Inno Pharmchem Major Business
  • 2.17.3 Ningbo Inno Pharmchem Bicyclic Peptide Drugs Product and Services
  • 2.17.4 Ningbo Inno Pharmchem Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.17.5 Ningbo Inno Pharmchem Recent Developments/Updates
• 2.18 Dayang Chemicals
  • 2.18.1 Dayang Chemicals Details
  • 2.18.2 Dayang Chemicals Major Business
  • 2.18.3 Dayang Chemicals Bicyclic Peptide Drugs Product and Services
  • 2.18.4 Dayang Chemicals Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.18.5 Dayang Chemicals Recent Developments/Updates
• 2.19 Shanghai Lollane Biological Technology
  • 2.19.1 Shanghai Lollane Biological Technology Details
  • 2.19.2 Shanghai Lollane Biological Technology Major Business
  • 2.19.3 Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Product and Services
  • 2.19.4 Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.19.5 Shanghai Lollane Biological Technology Recent Developments/Updates
• 2.20 Dalian Meilun Biotech
  • 2.20.1 Dalian Meilun Biotech Details
  • 2.20.2 Dalian Meilun Biotech Major Business
  • 2.20.3 Dalian Meilun Biotech Bicyclic Peptide Drugs Product and Services
  • 2.20.4 Dalian Meilun Biotech Bicyclic Peptide Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  • 2.20.5 Dalian Meilun Biotech Recent Developments/Updates

3 Competitive Environment: Bicyclic Peptide Drugs by Manufacturer

• 3.1 Global Bicyclic Peptide Drugs Sales Quantity by Manufacturer (2019-2024)
• 3.2 Global Bicyclic Peptide Drugs Revenue by Manufacturer (2019-2024)
• 3.3 Global Bicyclic Peptide Drugs Average Price by Manufacturer (2019-2024)
• 3.4 Market Share Analysis (2023)
  • 3.4.1 Producer Shipments of Bicyclic Peptide Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
  • 3.4.2 Top 3 Bicyclic Peptide Drugs Manufacturer Market Share in 2023
  • 3.4.3 Top 6 Bicyclic Peptide Drugs Manufacturer Market Share in 2023
• 3.5 Bicyclic Peptide Drugs Market: Overall Company Footprint Analysis
  • 3.5.1 Bicyclic Peptide Drugs Market: Region Footprint
  • 3.5.2 Bicyclic Peptide Drugs Market: Company Product Type Footprint
  • 3.5.3 Bicyclic Peptide Drugs Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Bicyclic Peptide Drugs Market Size by Region
  • 4.1.1 Global Bicyclic Peptide Drugs Sales Quantity by Region (2019-2030)
  • 4.1.2 Global Bicyclic Peptide Drugs Consumption Value by Region (2019-2030)
  • 4.1.3 Global Bicyclic Peptide Drugs Average Price by Region (2019-2030)
• 4.2 North America Bicyclic Peptide Drugs Consumption Value (2019-2030)
• 4.3 Europe Bicyclic Peptide Drugs Consumption Value (2019-2030)
• 4.4 Asia-Pacific Bicyclic Peptide Drugs Consumption Value (2019-2030)
• 4.5 South America Bicyclic Peptide Drugs Consumption Value (2019-2030)
• 4.6 Middle East & Africa Bicyclic Peptide Drugs Consumption Value (2019-2030)

5 Market Segment by Type

• 5.1 Global Bicyclic Peptide Drugs Sales Quantity by Type (2019-2030)
• 5.2 Global Bicyclic Peptide Drugs Consumption Value by Type (2019-2030)
• 5.3 Global Bicyclic Peptide Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

• 6.1 Global Bicyclic Peptide Drugs Sales Quantity by Application (2019-2030)
• 6.2 Global Bicyclic Peptide Drugs Consumption Value by Application (2019-2030)
• 6.3 Global Bicyclic Peptide Drugs Average Price by Application (2019-2030)

7 North America

• 7.1 North America Bicyclic Peptide Drugs Sales Quantity by Type (2019-2030)
• 7.2 North America Bicyclic Peptide Drugs Sales Quantity by Application (2019-2030)
• 7.3 North America Bicyclic Peptide Drugs Market Size by Country
  • 7.3.1 North America Bicyclic Peptide Drugs Sales Quantity by Country (2019-2030)
  • 7.3.2 North America Bicyclic Peptide Drugs Consumption Value by Country (2019-2030)
  • 7.3.3 United States Market Size and Forecast (2019-2030)
  • 7.3.4 Canada Market Size and Forecast (2019-2030)
  • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

• 8.1 Europe Bicyclic Peptide Drugs Sales Quantity by Type (2019-2030)
• 8.2 Europe Bicyclic Peptide Drugs Sales Quantity by Application (2019-2030)
• 8.3 Europe Bicyclic Peptide Drugs Market Size by Country
  • 8.3.1 Europe Bicyclic Peptide Drugs Sales Quantity by Country (2019-2030)
  • 8.3.2 Europe Bicyclic Peptide Drugs Consumption Value by Country (2019-2030)
  • 8.3.3 Germany Market Size and Forecast (2019-2030)
  • 8.3.4 France Market Size and Forecast (2019-2030)
  • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  • 8.3.6 Russia Market Size and Forecast (2019-2030)
  • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

• 9.1 Asia-Pacific Bicyclic Peptide Drugs Sales Quantity by Type (2019-2030)
• 9.2 Asia-Pacific Bicyclic Peptide Drugs Sales Quantity by Application (2019-2030)
• 9.3 Asia-Pacific Bicyclic Peptide Drugs Market Size by Region
  • 9.3.1 Asia-Pacific Bicyclic Peptide Drugs Sales Quantity by Region (2019-2030)
  • 9.3.2 Asia-Pacific Bicyclic Peptide Drugs Consumption Value by Region (2019-2030)
  • 9.3.3 China Market Size and Forecast (2019-2030)
  • 9.3.4 Japan Market Size and Forecast (2019-2030)
  • 9.3.5 South Korea Market Size and Forecast (2019-2030)
  • 9.3.6 India Market Size and Forecast (2019-2030)
  • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

• 10.1 South America Bicyclic Peptide Drugs Sales Quantity by Type (2019-2030)
• 10.2 South America Bicyclic Peptide Drugs Sales Quantity by Application (2019-2030)
• 10.3 South America Bicyclic Peptide Drugs Market Size by Country
  • 10.3.1 South America Bicyclic Peptide Drugs Sales Quantity by Country (2019-2030)
  • 10.3.2 South America Bicyclic Peptide Drugs Consumption Value by Country (2019-2030)
  • 10.3.3 Brazil Market Size and Forecast (2019-2030)
  • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

• 11.1 Middle East & Africa Bicyclic Peptide Drugs Sales Quantity by Type (2019-2030)
• 11.2 Middle East & Africa Bicyclic Peptide Drugs Sales Quantity by Application (2019-2030)
• 11.3 Middle East & Africa Bicyclic Peptide Drugs Market Size by Country
  • 11.3.1 Middle East & Africa Bicyclic Peptide Drugs Sales Quantity by Country (2019-2030)
  • 11.3.2 Middle East & Africa Bicyclic Peptide Drugs Consumption Value by Country (2019-2030)
  • 11.3.3 Turkey Market Size and Forecast (2019-2030)
  • 11.3.4 Egypt Market Size and Forecast (2019-2030)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

• 12.1 Bicyclic Peptide Drugs Market Drivers
• 12.2 Bicyclic Peptide Drugs Market Restraints
• 12.3 Bicyclic Peptide Drugs Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Bicyclic Peptide Drugs and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Bicyclic Peptide Drugs
• 13.3 Bicyclic Peptide Drugs Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Bicyclic Peptide Drugs Typical Distributors
• 14.3 Bicyclic Peptide Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source